MARY EBERHART: Open Payments
NPI 1952318297 · CROSSROADS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 21 payments from 6 companies in 2025. Trend: 2023 $361 · 2024 $470 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $210 |
| Novo Nordisk Inc | 3 | $62 |
| Lilly USA, LLC | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: UBRELVY, MOUNJARO, VRAYLAR, QULIPTA, Ozempic, Kerendia, Rybelsus, Wegovy.
Industry payments across TX — which companies pay providers there.
